Risk Factors of Gastrointestinal Bleeding in Patients Receiving New Oral Anticoagulants

New oral anticoagulants (NOACs) are now widely used for the prevention and treatment of venous thrombosis, and for the prevention of stroke and systemic embolism in patients with atrial fibrillation. As compared with warfarin, NOACs have the advantage of rapid onset of action and less drug interacti...

Full description

Bibliographic Details
Published in:The Korean Journal of Helicobacter and Upper Gastrointestinal Research
Main Author: Ju Yup Lee
Format: Article
Language:English
Published: Korean College of Helicobacter and Upper Gastrointestinal Research 2018-12-01
Subjects:
Online Access:http://www.helicojournal.org/journal/view.html?doi=10.7704/kjhugr.2018.18.4.219